YDMI
TEVA icon

Y.D. More Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Y.D. More Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.7M Buy
2,619,250
+1,001,450
+62% +$33.4M 2.76% 10
2026
Q1 		$48.7M Buy
1,617,800
+1,900
+0.1% +$61.1K 1.91% 11
2025
Q4 		$50.4M Hold
1,615,900
– – 2.42% 10
2025
Q3 		$32.6M Buy
1,615,900
+683,150
+73% +$12M 1.84% 12
2025
Q2 		$15.6M Buy
932,750
+846,500
+981% +$13.7M 1.08% 19
2025
Q1 		$1.33M Sell
86,250
-12,450
-13% -$222K 0.12% 97
2024
Q4 		$2.18M Sell
98,700
-7,100
-7% -$129K 0.2% 74
2024
Q3 		$1.91M Buy
105,800
+300
+0.3% +$5.25K 0.2% 79
2024
Q2 		$1.71M Buy
105,500
+6,900
+7% +$106K 0.17% 77
2024
Q1 		$1.39M Buy
98,600
+23,180
+31% +$292K 0.25% 74
2023
Q4 		$787K Sell
75,420
-500
-0.7% -$4.67K 0.15% 87
2023
Q3 		$774K Buy
75,920
+500
+0.7% +$4.66K 0.15% 90
2023
Q2 		$568K Hold
75,420
– – 0.13% 84
2023
Q1 		$667K Sell
75,420
-4,000
-5% -$39.6K 0.15% 71
2022
Q4 		$742K Buy
+79,420
New +$693K 0.18% 81

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Y.D. More Investments's TEVA Position: Q2 2026 in Review

Y.D. More Investments increased its Teva Pharmaceuticals (TEVA) stake by 62% in Q2 2026, buying an estimated $33.4M and bringing the position to 2,619,250 shares worth $88.7M. The position accounts for 2.76% of the portfolio, ranked #10.

Y.D. More Investments first reported a position in TEVA in Q4 2022 and has held it in 15 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Y.D. More Investments held 2,619,250 shares of Teva Pharmaceuticals worth $88.7M as of Q2 2026.
  • Y.D. More Investments bought 1,001,450 Teva Pharmaceuticals shares in Q2 2026, an estimated $33.4M.
  • Teva Pharmaceuticals made up 2.76% of Y.D. More Investments's portfolio in Q2 2026, its #10 holding.
  • Y.D. More Investments first reported a position in Teva Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Y.D. More Investments's 13F filing for Q2 2026, filed 5 Aug 2026.